Home > > > Report Detail

Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2019-2025

Publisher Name :
Date: 12-Jul-2019
No. of pages: 97
Inquire Before Buying

Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.

NASH is projected to lead the cause of liver transplantation in the U.S. in the coming years. Some major factors such as higher prevalence of NASH, expected launch of pipeline drugs, and higher number of unmet needs drive the growth of this market. However, poor diagnosis of NASH due to the lack of ideal diagnostic technologies limit the growth of the NASH market.

At present, vitamin E & pioglitazone segment dominates the non-alcoholic steatohepatitis (NASH) market, due to efficacy.

Asia-Pacific presents lucrative opportunities for the key players operating in the non-alcoholic steatohepatitis (NASH) market. Some factors such as growth in diagnostic techniques, rapid rise in prevalence NASH, growth in economies, and increase in demand for NASH therapeutics drive the market growth in Asia-Pacific.

In 2018, the global Nonalcoholic Steatohepatitis (NASH) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Nonalcoholic Steatohepatitis (NASH) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nonalcoholic Steatohepatitis (NASH) development in United States, Europe and China.

The key players covered in this study

- Tobira Therapeutics

- Cadila Healthcare

- Conatus Pharmaceuticals

- Galmed Pharmaceuticals

- Gemphire Therapeutics

- Genfit

- Gilead Sciences

- Intercept Pharmaceuticals

- Novartis International

- Shire

Market segment by Type, the product can be split into

- Vitamin E & Pioglitazone

- Ocaliva

- Elafibranor

- Selonsertib & Cenicriviroc

Market segment by Application, split into

- Hospital Pharmacy

- Online Provider

- Retail Pharmacy  

Market segment by Regions/Countries, this report covers

- United States

- Europe

- China

- Japan

- Southeast Asia

- India

- Central & South America

The study objectives of this report are:

- To analyze global Nonalcoholic Steatohepatitis (NASH) status, future forecast, growth opportunity, key market and key players.

- To present the Nonalcoholic Steatohepatitis (NASH) development in United States, Europe and China.

- To strategically profile the key players and comprehensively analyze their development plan and strategies.

- To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Nonalcoholic Steatohepatitis (NASH) are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Nonalcoholic Steatohepatitis (NASH) Market Size, Status and Forecast 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type (2014-2025)
1.4.2 Vitamin E & Pioglitazone
1.4.3 Ocaliva
1.4.4 Elafibranor
1.4.5 Selonsertib & Cenicriviroc
1.5 Market by Application
1.5.1 Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Online Provider
1.5.4 Retail Pharmacy  
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Nonalcoholic Steatohepatitis (NASH) Market Size
2.2 Nonalcoholic Steatohepatitis (NASH) Growth Trends by Regions
2.2.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (2014-2025)
2.2.2 Nonalcoholic Steatohepatitis (NASH) Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Nonalcoholic Steatohepatitis (NASH) Market Size by Manufacturers
3.1.1 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2014-2019)
3.1.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Nonalcoholic Steatohepatitis (NASH) Market Concentration Ratio (CR5 and HHI)
3.2 Nonalcoholic Steatohepatitis (NASH) Key Players Head office and Area Served
3.3 Key Players Nonalcoholic Steatohepatitis (NASH) Product/Solution/Service
3.4 Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019)
4.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019)
5 United States
5.1 United States Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
5.2 Nonalcoholic Steatohepatitis (NASH) Key Players in United States
5.3 United States Nonalcoholic Steatohepatitis (NASH) Market Size by Type
5.4 United States Nonalcoholic Steatohepatitis (NASH) Market Size by Application
6 Europe
6.1 Europe Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
6.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Europe
6.3 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type
6.4 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application
7 China
7.1 China Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
7.2 Nonalcoholic Steatohepatitis (NASH) Key Players in China
7.3 China Nonalcoholic Steatohepatitis (NASH) Market Size by Type
7.4 China Nonalcoholic Steatohepatitis (NASH) Market Size by Application
8 Japan
8.1 Japan Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
8.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Japan
8.3 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Type
8.4 Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
9.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Southeast Asia
9.3 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Type
9.4 Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Application
10 India
10.1 India Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
10.2 Nonalcoholic Steatohepatitis (NASH) Key Players in India
10.3 India Nonalcoholic Steatohepatitis (NASH) Market Size by Type
10.4 India Nonalcoholic Steatohepatitis (NASH) Market Size by Application
11 Central & South America
11.1 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size (2014-2019)
11.2 Nonalcoholic Steatohepatitis (NASH) Key Players in Central & South America
11.3 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Type
11.4 Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Application
12 International Players Profiles
12.1 Tobira Therapeutics
12.1.1 Tobira Therapeutics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.1.4 Tobira Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.1.5 Tobira Therapeutics Recent Development
12.2 Cadila Healthcare
12.2.1 Cadila Healthcare Company Details
12.2.2 Company Description and Business Overview
12.2.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.2.4 Cadila Healthcare Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.2.5 Cadila Healthcare Recent Development
12.3 Conatus Pharmaceuticals
12.3.1 Conatus Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.3.4 Conatus Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.3.5 Conatus Pharmaceuticals Recent Development
12.4 Galmed Pharmaceuticals
12.4.1 Galmed Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.4.4 Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.4.5 Galmed Pharmaceuticals Recent Development
12.5 Gemphire Therapeutics
12.5.1 Gemphire Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.5.4 Gemphire Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.5.5 Gemphire Therapeutics Recent Development
12.6 Genfit
12.6.1 Genfit Company Details
12.6.2 Company Description and Business Overview
12.6.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.6.4 Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.6.5 Genfit Recent Development
12.7 Gilead Sciences
12.7.1 Gilead Sciences Company Details
12.7.2 Company Description and Business Overview
12.7.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.7.4 Gilead Sciences Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.7.5 Gilead Sciences Recent Development
12.8 Intercept Pharmaceuticals
12.8.1 Intercept Pharmaceuticals Company Details
12.8.2 Company Description and Business Overview
12.8.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.8.4 Intercept Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.8.5 Intercept Pharmaceuticals Recent Development
12.9 Novartis International
12.9.1 Novartis International Company Details
12.9.2 Company Description and Business Overview
12.9.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.9.4 Novartis International Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.9.5 Novartis International Recent Development
12.10 Shire
12.10.1 Shire Company Details
12.10.2 Company Description and Business Overview
12.10.3 Nonalcoholic Steatohepatitis (NASH) Introduction
12.10.4 Shire Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
12.10.5 Shire Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Nonalcoholic Steatohepatitis (NASH) Key Market Segments
Table Key Players Nonalcoholic Steatohepatitis (NASH) Covered
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type 2014-2025
Figure Vitamin E & Pioglitazone Figures
Table Key Players of Vitamin E & Pioglitazone
Figure Ocaliva Figures
Table Key Players of Ocaliva
Figure Elafibranor Figures
Table Key Players of Elafibranor
Figure Selonsertib & Cenicriviroc Figures
Table Key Players of Selonsertib & Cenicriviroc
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacy Case Studies
Figure Online Provider Case Studies
Figure Retail Pharmacy   Case Studies
Figure Nonalcoholic Steatohepatitis (NASH) Report Years Considered
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2025 (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2014-2025 (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions 2014-2019 (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2014-2019
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2014-2019
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Regions 2019
Table Market Top Trends
Table Global Nonalcoholic Steatohepatitis (NASH) Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Share by Manufacturers (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Share by Manufacturers in 2018
Table Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Nonalcoholic Steatohepatitis (NASH) Product/Solution/Service
Table Date of Enter into Nonalcoholic Steatohepatitis (NASH) Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Type (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Type (2014-2019)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Application (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Market Share by Application (2014-2019)
Figure Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Application in 2018
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table United States Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table United States Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table United States Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Europe Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Europe Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Europe Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure China Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table China Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table China Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table China Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-20189) (Million US$)
Table China Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table China Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table China Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Japan Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Japan Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Japan Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure India Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table India Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table India Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table India Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table India Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table India Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table India Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Figure Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Nonalcoholic Steatohepatitis (NASH) Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Nonalcoholic Steatohepatitis (NASH) Market Share (2018-2019)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2014-2019) (Million US$)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2014-2019)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2014-2019) (Million US$)
Table Central & South America Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2014-2019)
Table Tobira Therapeutics Company Details
Table Tobira Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019) (Million US$)
Figure Tobira Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Tobira Therapeutics Recent Development
Table Cadila Healthcare Company Details
Table Cadila Healthcare Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Cadila Healthcare Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Cadila Healthcare Recent Development
Table Conatus Pharmaceuticals Company Details
Table Conatus Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Conatus Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Conatus Pharmaceuticals Recent Development
Table Galmed Pharmaceuticals Company Details
Table Galmed Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Galmed Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Galmed Pharmaceuticals Recent Development
Table Gemphire Therapeutics Company Details
Table Gemphire Therapeutics Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Gemphire Therapeutics Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Gemphire Therapeutics Recent Development
Table Genfit Company Details
Table Genfit Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Genfit Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Genfit Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Gilead Sciences Recent Development
Table Intercept Pharmaceuticals Company Details
Table Intercept Pharmaceuticals Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Intercept Pharmaceuticals Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Intercept Pharmaceuticals Recent Development
Table Novartis International Company Details
Table Novartis International Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Novartis International Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Novartis International Recent Development
Table Shire Company Details
Table Shire Revenue in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)(Million US$)
Figure Shire Revenue Growth Rate in Nonalcoholic Steatohepatitis (NASH) Business (2014-2019)
Table Shire Recent Development
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Regions (Million US$) 2019-2025
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Regions (2019-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size Share by Regions in 2025
Figure United States Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Europe Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure China Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Japan Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure India Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast (2019-2025)(Million USD)
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product (2019-2025) (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product (2019-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Product in 2025
Table Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2025) (Million US$)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2019-2025)
Figure Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs